Cargando…

Prevention of COVID-19 in patients with IBD

Detalles Bibliográficos
Autores principales:	Segal, Jonathan P, Quraishi, Mohammed Nabil, Bhala, Neeraj, Brookes, Matthew James
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7237355/ https://www.ncbi.nlm.nih.gov/pubmed/32442546 http://dx.doi.org/10.1016/S2468-1253(20)30153-9

Ejemplares similares

An urgent need to institute COVID-19 testing in patients with IBD experiencing flares
por: Quraishi, Mohammed Nabil, et al.
Publicado: (2020)

COVID-19 vaccinations in patients with inflammatory bowel disease
por: Kumar, Aditi, et al.
Publicado: (2020)

Personalised medicine in IBD: don’t dispose of the sledgehammer just yet
por: Kumar, Aditi, et al.
Publicado: (2022)

The impact of SARS-CoV-2 variants on IBD management
por: Segal, Jonathan P, et al.
Publicado: (2021)

COVID-19—from mucosal immunology to IBD patients
por: Weidinger, Carl, et al.
Publicado: (2021)

Prevention of COVID-19 in patients with IBD – Authors' reply
por: Ding, Nik Sheng, et al.
Publicado: (2020)

Implications of recurrent SARS-CoV-2 outbreaks for IBD management
por: Segal, Jonathan P, et al.
Publicado: (2020)

Characteristics and Outcomes of IBD Patients with COVID-19 on Tofacitinib Therapy in the SECURE-IBD Registry
por: Agrawal, Manasi, et al.
Publicado: (2020)

COVID-19 in IBD: The experience of a single tertiary IBD center
por: Rizzello, Fernando, et al.
Publicado: (2021)

Assessment, endoscopy, and treatment in patients with acute severe ulcerative colitis during the COVID-19 pandemic (PROTECT-ASUC): a multicentre, observational, case-control study
por: Sebastian, Shaji, et al.
Publicado: (2021)

IBD in the Time of COVID19
por: Moss, Alan, et al.
Publicado: (2020)

COVID-19 and immunomodulation in IBD
por: Neurath, Markus F
Publicado: (2020)

The Impact of Vedolizumab on COVID-19 Outcomes Among Adult IBD Patients in the SECURE-IBD Registry
por: Agrawal, Manasi, et al.
Publicado: (2021)

Impact of the coronavirus infectious disease (COVID-19) pandemic on the provision of inflammatory bowel disease (IBD) antenatal care and outcomes of pregnancies in women with IBD
por: Selinger, Christian Philipp, et al.
Publicado: (2021)

The analysis of gut microbiota in patients with bile acid diarrhoea treated with colesevelam
por: Kumar, Aditi, et al.
Publicado: (2023)

Protecting patients with IBD during the COVID-19 pandemic
por: Fiorino, Gionata, et al.
Publicado: (2020)

Life in lockdown: experiences of patients with IBD during COVID-19
por: Harris, Richard James, et al.
Publicado: (2020)

Psychological reaction to Covid-19 of Italian patients with IBD
por: Savarese, Mariarosaria, et al.
Publicado: (2021)

Managing IBD in the COVID-19 era
por: Scalzo, Nicholas, et al.
Publicado: (2023)

Excessive anxiety in IBD patients is unnecessary for COVID-19
por: Wang, Hong-Gang, et al.
Publicado: (2020)

Fr494 THE IMPACT OF VEDOLIZUMAB THERAPY ON COVID-19 OUTCOMES IN ADULT IBD PATIENTS IN THE SECURE-IBD REGISTRY
por: Agrawal, Manasi, et al.
Publicado: (2021)

Su1483: COVID-19 VACCINES ARE HIGHLY EFFECTIVE IN PATIENTS WITH IBD: OUTCOMES FROM THE SCOUT IBD COHORT
por: Hong, Simon J., et al.
Publicado: (2022)

Inflammatory bowel disease patient‐reported quality assessment should drive service improvement: a national survey of UK IBD units and patients
por: Hawthorne, A. Barney, et al.
Publicado: (2022)

Impact of COVID-19 Pandemic on the Quality of Life of IBD Patients
por: Gavrilescu, Otilia, et al.
Publicado: (2022)

The impact of COVID-19 pandemic on IBD endoscopic procedures in a high-volume IBD Center
por: Lopetuso, Loris Riccardo, et al.
Publicado: (2020)

Su1482: SCOUT IBD: SURVEILLANCE OF COVID-19 IMPACT ON LONG-TERM OUTCOMES IN IBD
por: Hong, Simon J., et al.
Publicado: (2022)

Sharpening the global focus on ethnicity and race in the time of COVID-19
por: Bhala, Neeraj, et al.
Publicado: (2020)

What Is the Incidence of COVID-19 in Patients With IBD in Western Countries?
por: Taxonera, Carlos, et al.
Publicado: (2021)

Alcohol-related harms and the certainty of deaths and taxes
por: Bhala, Neeraj B.
Publicado: (2022)

IBD in the COVID-19 era: the value of international collaboration
por: Brenner, Erica J, et al.
Publicado: (2020)

COVID-19: Colorectal cancer endoscopic surveillance in IBD
por: Din, Shahida, et al.
Publicado: (2021)

Immunosuppressive IBD drugs and COVID-19 vaccine immunogenicity
por: Hindson, Jordan
Publicado: (2022)

COVID-19 Vaccination in Inflammatory Bowel Disease (IBD)
por: Kubas, Aleksandra, et al.
Publicado: (2022)

Covid-19 and Patients with IBD: Who Is at Highest Risk for Severe Complications?
por: Horst, Sara
Publicado: (2021)

Quality of life in patients with IBD during the COVID-19 pandemic in the Netherlands
por: de Bock, Ellen, et al.
Publicado: (2021)

Fr098 IMPACT OF COVID-19 PANDEMIC IN IBD PATIENT CARE
por: Dahiya, Monica, et al.
Publicado: (2021)

Perception and Attitude of Lebanese IBD Patients During the COVID-19 Pandemic
por: Mikhael, Elio, et al.
Publicado: (2023)

Oral and Intravenous Iron Therapy Differentially Alter the On- and Off-Tumor Microbiota in Anemic Colorectal Cancer Patients
por: Phipps, Oliver, et al.
Publicado: (2021)

The Impact of the COVID-19 Pandemic on IBD Care in Alberta: Patient and Provider Perspectives
por: Dahiya, Monica, et al.
Publicado: (2022)

Increased Hospitalization for IBD Patients Seen in the ER During the COVID-19 Pandemic
por: Malhi, Gurpreet, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n9brqohkii9lcnoqs54htp4avm